Venture-Backed Startups

Cured builds cloud-based enterprise software for healthcare organizations to modernize operations and improve patient and employee experiences. The company provides technology solutions that enable healthcare providers and payers to execute strategic initiatives through agile, consumer-grade platforms.

2 investors

cult.fit offers fitness memberships (cultpass) providing access to group classes, gyms, at-home workouts, and sports facilities, along with weight-loss coaching, workout gear, and wellness services. It operates as a consumer fitness and wellness brand in India, with additional offerings for diabetes reversal and mental fitness.

4 investors

Cure Genetics develops two biotechnology platforms: AIMS CAR-NKT, a cell therapy targeting solid tumors such as clear cell renal carcinoma, and the VELP directed-evolution library platform for gene therapy applications addressing the nervous system, heart, and kidneys. Its VELP platform has licensing collaborations with pharmaceutical companies including Boehringer Ingelheim.

2 investors

Curejoy is a digital health and wellness content platform that aggregates information about natural health practices and home remedies for a global audience. It serves health-conscious consumers seeking credible wellness information and expert advice through its website, social media, and newsletters.

1 investor

Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.

0 investors

CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.

0 investors

Curelink is an applied AI lab focused on chronic care, developing technology intended to make continuous, adaptive care widely accessible. It aims to address gaps in the current system for managing chronic disease.

1 investor

A telemedicine and diagnostic platform that enables patients to upload prescriptions and access lab tests across multiple Indian cities. The company connects patients with diagnostic services and tests through its mobile app and website.

1 investor

Curemark is a clinical-stage biopharmaceutical company developing therapies for neuro-developmental and neurodegenerative disorders. Its lead candidate, CM-AT, is a disorder-modifying therapy for Autism.

0 investors

CureMatch provides a digital decision support system that guides oncologists in selecting personalized cancer drug treatments based on individual patients' molecular tumor profiles.

1 investor

CureMint provides a software platform that streamlines procurement for dental practices, replacing outdated systems to reduce overspending and operational inefficiencies. The company serves dental organizations across the United States with cloud-based procurement solutions.

1 investor

Curenta offers AI-powered EMR software for senior living and assisted living facilities, automating tasks such as medication passes (eMAR), admissions data entry, charting, billing, and compliance checks. The platform functions as a central system for managing facility operations and resident care.

1 investor

0 investors

CUREOSITY develops CUREO, a virtual reality therapy system used in rehabilitation institutions to treat patients with motorsensory and cognitive impairments. The company serves clinics and practices, primarily in Germany but also globally, within the digital health and medtech sector.

1 investor

Curesign is a medical device company developing a system that combines sensors with signal processing and big data tools to help oncologists tailor patient-specific cancer treatments. Its technology has been demonstrated in preclinical studies and is being developed into a commercial product for oncology trials.

1 investor

Cureskin is a mobile app that uses AI to give users continuous access to dermatologist care for managing skin and hair conditions. It targets consumers seeking everyday skin and hair care treatment.

5 investors

Curesponse applies science and technology to improve cancer treatment, bringing together medical executives, scientists, and clinical and regulatory experts. The company operates laboratories in the UK and Israel to support oncology treatment decisions.

1 investor

Curestream develops an artificial pancreas system for diabetes management, combining an AI insulin control algorithm, modular insulin pump, and blood glucose management app to automate insulin delivery without user intervention.

1 investor

Cureus is an open-access medical journal platform that publishes peer-reviewed research. The platform uses technology and structured workflows to accelerate the peer review and publication process for medical research across all specialties.

1 investor

Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases. It operates in clinical-stage vaccine development.

4 investors

Curex offers at-home prescription allergy relief through sublingual immunotherapy treatments, personalized based on individual allergy testing. The company serves allergy sufferers seeking an alternative to traditional allergy shots through virtual visits.

4 investors

Curfex is a licensed Money Service Operator (MSO) in Hong Kong offering cross-border payment and settlement infrastructure for financial institutions, licensed platforms, and enterprise clients, with a focus on fund movement into and out of Japan. It operates a dual-entity regulated stack across Hong Kong and Japan alongside its affiliate Fukugu, Inc.

1 investor

Curi Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.

1 investor

Curia provides R&D and manufacturing services to help clients address complex scientific and production challenges. The company employs over 3,000 scientists and specialists across 20 global locations.

1 investor